Member Info for Kevinl1977

Axe
You must be very wealthy if you just took a ‘punt’ for £20k.
GL

If there are any true gems doc we will find out via an RNS, in good time.
That will hopefully be next week.

Manifesto
I hope you’re well.
As much as I would like an application for EUA, I don’t see it. There was much talk from RM pre-P3 readout that if data was good and Covid was still around then EUA would be applied for.
I have not seen anything from the Company since that dreadful day that suggests EUA would be made?
Pre-p3 readout there was an incredible amount of evidence on here from so many amazing posters; hence why I over indulged in this share.
I would love nothing more than impressive data to be unearthed from the DD, but until that happens I don’t see it.
RM talks of another trial. We just failed a 623 patient one on both primary and secondary endpoints, due to SOC changes.
Why will a new trial be any different in terms of results, when SOC will remain as high?
A takeover may come with new data, but that won’t recoup all my losses and Synairgen definitely do not have the scope, ability or workforce to bring this expensive drug to market imo.
We needed amazing results from the Sprinter trial , as whatever people think on here, the cost of drugs DEFINITELY matter! I know we have discussed price of ICU stays v our drug but there are much cheaper alternatives that Governments will prefer to invest in, unless the evidence is overwhelming imo.
I hope I am wrong and that something can be salvaged from the DD/Active data, wherever that is?
GLA LTHs

It’s pretty clear that they haven’t yet finished analysing the data, which is cutting it fine if that’s the case.
‘As announced on 21 February 2022, Synairgen is in the process of analysing the topline and full dataset from the SPRINTER Phase 3 study in order to better understand all of the findings. The findings of this analysis will be announced ‘without delay’ once complete in accordance with regulatory obligations and presented and/or published in a peer-review journal.’

‘The SPRINTER trial pointed to an encouraging trend in prevention of progression to severe disease and death (36% reduction in the pre-defined per protocol population), which the Company and its clinical advisors strongly believe merits further investigation in a platform trial which the Company is actively investigating.’
Hopefully, an RNS on Monday.
GLA

Thanks Titania.
More glowing evidence; does it amount to anything for us?
ATB

Manifesto
Following the disappointing failed endpoints last time, I think it’s sensible to be level headed.
I don’t see how ramping this thing up will affect anything.
The results of the DD are nearly upon us; time will tell.
As I’ve said before, I won’t be buying any more shares as I’ve invested more than enough in this company.
I sincerely hope that we recover as it means I can retire earlier than planned, but unless they uncover some gems it won’t.
I’m not sure where you get 10p and 15p from? The price is 24p and I have many of them, they are the facts for me.
GLA

Manifesto
Sorry to be a fly in the ointment but ‘pretty risk free?’
I doubt many will agree with you on that one; a very naive view.
I will never think that way again regarding shares on the AIM market.
GLA LTHs

Timster
MMs will delay trades every day to manipulate the SP.
GLA

If the company has any news/data, etc then it must report this to the market via an RNS.
This is the law!
So, in short, they don’t have the news/data, yet.
These trials often run way over, so don’t panic.

Doc
Interesting and shrewd spot.
Hope you’re well.
Watching from afar and hoping that DD brings us hope and joy at the Conference.
ATB

Thanks trinity - top man!
Excellent post.

Uncrossing trade happens when the stock market closes - @4.35pm

Just green bin folks.
Much easier.
Burstead obviously had no attention as a child.
Sorry state of affairs, really.

TtB
ATB

The SOC across the different hospitals was questionable and fluctuated in the different countries.
Deep dive is currently happening and recovery is hopefully possible.
Nevertheless, don’t want to cross talk another stock as that wasn’t my intention, but thought it was worth mentioning to keep feet on the ground and hopefully SP will keep going up for investors.
ATB

As I say, I wish investors all the best but let’s go for £1.50 and then £2, first.
Where do people just randomly get £80 from?
Mcap of billions.
GLA

Axe
I must get myself one of those crystal balls too.

Tommy
It appears that in many hospitals the SOC was a ****show and clearly the quality and efficiency across the various hospitals was wide ranging.
I don’t know what Synairgen could have done to impact/control/improve this as the number of hospitals involved were plenty?
Surely, this was the responsibility or the individual hospitals to deliver the required SOC?
Can some of the data can be written off and placed down to SOC issues?
ATB

A word of warning.
This very same thing happened on the Synairgen board a.few months back. Ridiculous figures being thrown around when the price was at £2.
The evidence for a multi bagger was absolutely overwhelming, but despite this, the trial failed to meet its endpoints and the SP crashed to 20p.
I wish everyone success, but also be prepared that nothing is ever a definite on AIM.
Good luck all.

Andy
My concern is that the only people discussing EUA are investors on this board.
So many of us have discussed what if we add A + B + C and then apply for EUA.
Since the dismal Monday RNS, not once have the Company mentioned EUA.
Hence, my concerns.